Zobrazeno 1 - 10
of 78
pro vyhledávání: '"I I, Kalinina"'
Autor:
G. G. Solopova, D. D. Baidildina, L. I. Zharikova, I. I. Kalinina, U. N. Petrova, Ye. V. Suntsova, O. V. Goronkova, L. A. Hachatryan, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan, M. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-15 (2022)
Standard therapy of high risk patients with Langerhans cell histiocytosis (LCH) is associated with essential risk of therapy failure. In the present study results of 2-clorodeoxyadenosine usage as alternative therapy in this group of patients are ana
Externí odkaz:
https://doaj.org/article/aff35ebb6ec14d3cbe54f0f6a680cf5f
Autor:
N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 5-13 (2022)
Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are presented. 105 children at the age from 2 weeks till 18 years (a median age — 10.8 years) are inc
Externí odkaz:
https://doaj.org/article/b5947a60a3844a338c3bdb12bb102b9d
Autor:
N. Yu. Shipovskaya, E. V. Samochatova, O. B. Polushkina, M. A. Maschan, I. I. Kalinina, A. N. Gracianskay, M. N. Kostileva, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 70-74 (2022)
Introduction of biosimilars in clinical practice results in substantial reduction of direct medical costs. However, limited data concerning safety and tolerance of biosimilars exist, especially in children. We conducted double blind randomized trial
Externí odkaz:
https://doaj.org/article/db4beeeafdcc46779093ed79607dbe40
Autor:
A. K. Ignatova, I. I. Kalinina, D. A. Venev, T. Yu. Salimova, D. A. Evseev, M. N. Sadovskaya, O. V. Goronkova, V. E. Matveev, U. N. Petrova, K. S. Antonova, D. D. Baydildina, M. E. Dubrovnaya, T. V. Konyukhova, Yu. V. Olshanskaya, D. S. Abramov, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 16, Iss 1, Pp 10-22 (2021)
Background. Extramedullary infiltration (EI) is relatively common in children with acute myeloid leukemia (AML) (up to 20-25 %). However, its clinical and prognostic significance remains poorly understood.Objective: to describe clinical features and
Externí odkaz:
https://doaj.org/article/14fb36d0acc24523992dfb11fa1cebf2
Autor:
D. S. Osipova, E. V. Raykina, E. I. Lyudovskikh, D. A. Evseev, I. I. Kalinina, D. D. Baydildina, A. M. Popov, A. A. Semchenkova, E. A. Burtsev, G. O. Bronin, A. A. Maschan, M. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:12-20
This article discusses the potential of droplet digital polymerase chain reaction (PCR) for the diagnostic detection and monitoring of the allelic load of the BRAF V600E mutation in circulating cell-free DNA and myeloid progenitor cell population in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4ddd9ce5ea4ca38ede49776d1c7366d
https://doi.org/10.24287/1726-1708-2023-22-1-12-20
https://doi.org/10.24287/1726-1708-2023-22-1-12-20
Autor:
E. I. Lyudovskikh, D. A. Evseev, D. S. Osipova, E. V. Raykina, I. I. Kalinina, D. D. Baidildina, A. A. Maschan, M. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:122-125
Here we report a clinical case of a patient with BRAF-positive Langerhans cell histiocytosis treated with combination therapy including trametinib. As the patient was undergoing long-term therapy with a BRAF inhibitor, his underlying disease reactiva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc1e84e29d5ce22dc9b4267f51c05542
https://doi.org/10.24287/1726-1708-2023-22-1-122-125
https://doi.org/10.24287/1726-1708-2023-22-1-122-125
Autor:
G. B. Movsisyan, A. D. Komarova, K. A. Kulikov, I. I. Kalinina, M. M. Lokhmatov, V. I. Oldakovskiy, R. F. Tepaev, E. A. Roslavtseva, A. S. Potapov, N. E. Shchigoleva, A. I. Materikin, K. V. Savostyanov
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:110-121
Exudative enteropathy is a clinical syndrome characterized by excessive loss of proteins through the gastrointestinal tract and is a rare complication of various gastrointestinal diseases. One of the rarest causes of protein malabsorption is Langerha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f969ca0ca5df71b9fec3dbe15c3b53dc
https://doi.org/10.24287/1726-1708-2023-22-1-110-121
https://doi.org/10.24287/1726-1708-2023-22-1-110-121
Autor:
I. I. Kalinina, D. A. Venyov, Yu. V. Olshanskaya, M. N. Sadovskaya, O. V. Goronkova, T. Yu. Salimova, U. N. Petrova, D. D. Baidildina, E. V. Suntsova, D. A. Evseev, V. E. Matveev, K. S. Antonova, I. G. Khamin, M. Е. Dubrovina, E. A. Zerkalenkova, M. V. Gaskova, A. M. Popov, S. A. Kashpor, A. I. Mandzhieva, T. V. Konyukhova, L. A. Khachatryan, D. V. Litvinov, D. N. Balashov, L. N. Shelikhova, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:20-35
Over the past years, the outcomes of patients with acute myeloid leukemia (AML) have significantly improved due to the use of intensive chemotherapy, more effective supportive therapy, and the availability of allogeneic hematopoietic stem cell transp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::552ffa7a0d0e84579992ae4d12a8081b
https://doi.org/10.24287/1726-1708-2022-21-1-20-35
https://doi.org/10.24287/1726-1708-2022-21-1-20-35
Autor:
E. V. Mikhailova, N. S. Mochalova, S. A. Kashpor, E. A. Zerkalenkova, T. V. Konyukhova, S. A. Plyasunova, Yu. V. Olshanskaya, I. I. Kalinina, M. A. Maschan, A. A. Maschan, G. A. Novichkova, A. M. Popov
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:42-48
Contemporary therapy of acute promyelocytic leukemia (APL) is based on the use of all-trans retinoic acid, which is effective against tumor cells harboring RARa gene rearrangements (most common – t(15;17)(q24;q21)/PML::RARa). In several studies, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2159f4679bd1c2da934c353ac65c3a80
https://doi.org/10.24287/1726-1708-2022-21-1-42-48
https://doi.org/10.24287/1726-1708-2022-21-1-42-48
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:148-153
Cystic angiomatosis is a rare disease characterized by disseminated multifocal hemangiomatous and/or lymphangiomatous cystic lesions of the skeleton with possible visceral organ involvement. Only a few dozens of such patients worldwide have been desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2319d7461dfe6c2d840daa5c877cb424
https://doi.org/10.24287/1726-1708-2021-20-4-148-153
https://doi.org/10.24287/1726-1708-2021-20-4-148-153